Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | 177Lu-RAD202 |
| Synonyms | |
| Therapy Description |
Limited information is currently available on 177Lu-RAD202, a putative radiolabeled antibody therapy targeting ERBB2 (HER2) (Mar 2025). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| 177Lu-RAD202 | 177LuRAD202|177Lu RAD202|RAD202|RAD 202|RAD-202 | HER2 (ERBB2) Antibody 79 | Limited information is currently available on 177Lu-RAD202, a putative radiolabeled antibody therapy targeting ERBB2 (HER2) (Mar 2025). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|---|---|---|---|---|---|
| NCT06824155 | Phase I | 177Lu-RAD202 | HEAT Trial (HER2 Antibody Therapy with Lutetium-177) (RAD202) | Recruiting | AUS | 0 |